ZenaTech Expands Drone as a Service (DaaS) for Government and Defense, Signing an Offer to Acquire a Virginia-Headquartered Tri-State Land Survey and Engineering Firm Serving Major US Federal Clients
VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces it has signed an offer to acquire a Virginia-headquartered land survey and civil engineering firm with operations in three states and expertise serving major US federal government agencies and regional infrastructure programs. Upon completion, this acquisition would mark ZenaTech’s first entry into the states of Virginia, North Carolina, and South Carolina, accelerating the Company’s expansion across the Southeast region of the US.
“This acquisition reinforces our DaaS business model expansion objectives to provide drone innovation supporting US federal government, defense, and infrastructure surveying,” said Shaun Passley, Ph.D., ZenaTech CEO. “With an established client base spanning federal agencies and regional construction markets, we are gaining both geographic reach and access to a high-value pipeline of projects where drone-based surveys and inspections can dramatically improve speed, precision and data quality for greater efficiency and precision.”
Founded in 2010 by an industry veteran, the target company delivers full-service land surveying, civil engineering, land planning, and 3D imaging. They hold active contracts with federal and state agencies and provide core infrastructure services such as land surveys for highways, bridges, and development projects.
ZenaTech’s Drone as a Service (DaaS) business model offers both business and government customers reduced costs and convenience to utilize drones to streamline legacy processes and manual tasks such as inspections, surveying, maintenance, precision agriculture and inventory management ─ there is no need to purchase drone hardware and software, find a drone pilot, manage maintenance and operation, or acquire regulatory approvals. The model also offers scalability to use more often or less often based on business needs and utilizes ZenaDrone’s multifunction AI autonomous drones.
About ZenaTech
ZenaTech (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company specializing in AI drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions for mission-critical business applications. Since 2017, the Company has leveraged its software development expertise and grown its drone design and manufacturing capabilities through ZenaDrone, to innovate and improve customer inspection, monitoring, safety, security, compliance, and surveying processes. With enterprise software customers using branded solutions in law enforcement, health, government, and industrial sectors, and drones being implemented in these plus agriculture, defense, and logistics sectors, ZenaTech’s portfolio of solutions helps drive exceptional operational efficiencies, accuracy, and cost savings. The Company operates through seven global offices in North America, Europe, Taiwan, and UAE, and is growing a DaaS business model and global partner network.
About ZenaDrone
ZenaDrone, a wholly owned subsidiary of ZenaTech, develops and manufactures autonomous business drone solutions that can incorporate machine learning software, AI, predictive modeling, Quantum Computing, and other software and hardware innovations. Created to revolutionize the hemp farming sector, its specialization has grown to multifunctional drone solutions for industrial surveillance, monitoring, inspection, tracking, process automation and defense applications. Currently, the ZenaDrone 1000 drone is used for crop management applications in agriculture and critical field cargo applications in the defense sector, the IQ Nano indoor drone is used for inventory management and security in the warehouse and logistics sectors, and the IQ Square is an indoor/outdoor drone designed for land survey and inspections use in commercial and defense sectors.
Contacts for more information:
Company, Investors and Media:
Linda Montgomery
ZenaTech
312-241-1415
Investors:
Michael Mason
CORE IR
Safe Harbor
This press release and related comments by management of ZenaTech, Inc. include “forward-looking statements” within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management’s expectations and projections regarding ZenaTech’s growth, results of operations, performance, and business prospects and opportunities. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology intended to identify forward-looking statements. Forward-looking information in this document includes, but is not limited to ZenaTech’s expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; expectations with respect to future production costs and capacity; ZenaTech's ability to deliver products to the market as currently contemplated, including its drone products including ZenaDrone 1000 and IQ Nano; ZenaTech’s anticipated cash needs and it’s needs for additional financing; ZenaTech’s intention to grow the business and its operations and execution risk; expectations with respect to future operations and costs; the volatility of stock prices and market conditions in the industries in which ZenaTech operates; political, economic, environmental, tax, security, and other risks associated with operating in emerging markets; regulatory risks; unfavorable publicity or consumer perception; difficulty in forecasting industry trends; the ability to hire key personnel; the competitive conditions of the industry and the competitive and business strategies of ZenaTech; ZenaTech’s expected business objectives for the next twelve months; ZenaTech’s ability to obtain additional funds through the sale of equity or debt commitments; investment capital and market share; the ability to complete any contemplated acquisitions; changes in the target markets; market uncertainty; ability to access additional capital, including through the listing of its securities in various jurisdictions; management of growth (plans and timing for expansion); patent infringement; litigation; applicable laws, regulations, and any amendments affecting the business of ZenaTech.
Latest News
/filters:format(webp)https://news.stocktwits-cdn.com/Screenshot_2025_11_05_at_4_07_14_PM_png_7fdae51a7e.webp)
/filters:format(webp)https://news.stocktwits-cdn.com/Logo_Stocktwits_PR_Desk_png_0c06f0d263.webp){kind=logo}
Stocktwits PR Desk·6h agoStocktwits PR Desk·6h ago/filters:format(webp)https://news.stocktwits-cdn.com/Screenshot_2025_11_05_at_9_39_57_AM_png_d5dba40ccd.webp)
Stocktwits PR Desk·13h ago/filters:format(webp)https://news.stocktwits-cdn.com/zenatech_lolo_png_2471abb4d3.webp)
Stocktwits PR Desk·2d ago/filters:format(webp)https://news.stocktwits-cdn.com/Screenshot_2025_11_03_at_12_46_14_PM_png_24e77e0ee6.webp)
Stocktwits PR Desk·2d ago/filters:format(webp)https://news.stocktwits-cdn.com/Screenshot_2025_11_03_at_12_05_04_PM_png_f39e1c93b2.webp)
Stocktwits PR Desk·2d agoGold Investment Dollars are Flooding into the Safe African Countries amidst Record Prices- Here’s 5 Stocks To Play The Renaissance
Investors who have been hesitant to explore gold stocks in African markets may be overlooking some of the most compelling opportunities of the coming decade. Gold prices have soared to unprecedented levels in 2025, at times, exceeding $3,500 per ounce. This historic rally is fueled by several factors, including persistent global inflation and economic instability, geopolitical tensions and uncertainty, particularly involving major economies like the U.S., as well as central banks, especially in China and India, increasing their gold reserves while reducing U.S. Treasury.
Why Africa? Safe Havens and High Returns
Turning to Africa, the continent is rich in natural resources. According to the World Gold Council, Africa is home to some of the largest gold reserves, with countries such as South Africa, Tanzania, Ghana, and Mali leading in terms of production. This positions Africa as a strategic destination for investors seeking both commodity and geographic diversification.
Amid these record prices, investment dollars are flowing into African countries perceived as relatively stable and “safe” for gold mining and trading. Several West and East African nations have emerged as top destinations due to their established mining codes and regulatory frameworks, political stability relative to other gold-rich regions, and ongoing infrastructure improvements and government initiatives to attract foreign investment
Investment Dynamics and Trends
Middle Eastern Backing: Investors from GCC countries have poured over $100 billion into African mining over the past decade, according to Afreximbank’s December 2024 report, with a focus on gold. The UAE is the largest investor and has invested approximately $59.4 billion, followed by Saudi Arabia with $25.6 billion.
Production Growth: Ghana’s gold output surged 19.3% in 2024 and is expected to increase gold output by 6.25% to 5.1 million ounces in 2025, driven by both artisanal and new large-scale mining projects. Similarly, Tanzania’s gold production reached an all-time high of 60,000 kilograms (approximately 1.93 million ounces) in 2024, up from 55,000 kilograms in 2023.
Government Initiatives: Many African governments are introducing policies such as tax incentives, infrastructure development, and regulatory reforms to attract and secure foreign investment in gold mining.
5 Stocks to Consider for High Returns and Strategic Investments in African Gold
1. Lake Victoria Gold (LVG)
Lake Victoria Gold (TSXV: LVG | OTCQB: LVGLF) is a junior gold exploration and development company focused primarily on the Lake Victoria Goldfield region in Tanzania. The company is rapidly growing through acquisitions and exploration in this prolific gold-producing area.
Key Projects and Operations:
LVG holds a 100% interest in the Tembo Gold Project located in northwest Tanzania, adjacent to Barrick Gold’s Bulyanhulu Mine, one of the largest gold mines in the region.
The Tembo Project has over 50,000 meters of drilling completed. Furthermore, the company has launched a 3,000-meter reverse circulation (RC) drilling program at the Ngula 1 prospect.
Previous drilling at Ngula 1 has yielded significant intercepts, including 17.23 g/t gold over 4 meters from 19 meters depth and 28.57 g/t gold over 3 meters from 54 meters. The new RC program will test a 300-meter stretch of the southern structural zone with holes spaced every 20 meters and depths up to 50 meters.
The drilling supports a proposed small-scale mining joint venture with Nyati Resources, which will use two processing plants to process mineralized material from the Tembo Project and nearby licenses.
On April 9, Lake Victoria Gold successfully converted its Tembo Project’s Prospecting License into four 10-year Mining Licenses. This legal advancement clears the path for formal development and enhances the project’s appeal to partners and investors.
The company also acquired the Imwelo Gold Project, situated immediately west of AngloGold Ashanti’s Geita Gold Mine, under Tanzanian mining licenses ML538/2015 and PML2637. This project benefits from proximity to a major producing mine and has an updated pre-feasibility study completed in 2021.
In 2021, LVG sold six non-core prospecting licenses near Bulyanhulu to Barrick for $6 million up front and up to $45 million in milestone payments, with Barrick also taking an equity position in LVG.
The company has also secured an equity investment and operational partnership with Taifa Group, Tanzania’s largest mining contractor. Through Taifa Mining, LVG will access extensive local mining expertise and a large fleet of equipment, reducing execution risk in exploration and development.
Why Invest in Lake Victoria Gold?
STRATEGIC POSITIONING IN A PROLIFIC GOLD DISTRICT: LVG’s projects are located in Tanzania’s most productive gold belt, adjacent to major mines like Barrick Gold’s Bulyanhulu Mine and AngloGold Ashanti’s Geita Gold Mine, which provides potential for resource growth and operational synergies.
UPTO $45 MILLION IN MILESTONE PAYMENTS: Barrick’s purchase of non-core licenses from LVG for $6 million up front and upto $45 million in milestone payments, along with an equity position, underscores the region’s potential and provides necessary funds to carry operations and advance exploration and development activities.
PARTNERSHIP WITH NYATI RESOURCES: The proposed small-scale mining joint venture with Nyati Resources, which provides access to a privately operated Carbon-in-Pulp (CIP) plant with up to 620 tonnes per day capacity reduces time to market.
EARLY-STAGE GROWTH POTENTIAL: As a junior explorer and developer, LVG’s stock is trading at $0.1420 and offers exposure to significant upside from successful exploration and development in a proven gold region.
FOCUSED AND LEAN OPERATION: With a small team and targeted project portfolio, the company can efficiently allocate capital to high-impact exploration and development activities.
RENEWED MINING LICENSES AND FINANCING: Recent license renewals and capital raises reduce regulatory and financial risks, supporting project advancement.
THE COMPANY’S LEADERSHIP: LVG’s leadership has decades of African mining experience and retains over 60% ownership, aligning closely with shareholder interests.
2. AngloGold Ashanti (AU)
AngloGold Ashanti (NYSE: AU) is a major global gold mining company with a strong presence in Africa, operating key mines such as Siguiri in Guinea (85% stake), Iduapriem and Obuasi in Ghana, Geita in Tanzania, Sukari in Egypt, and Kibali in the Democratic Republic of Congo. The company targets total gold production between 2.9 million and 3.225 million ounces in 2025, with 1.9 to 2.1 million ounces expected from its African operations.
Recent Highlights:
In Q1 2025, AngloGold Ashanti’s gold production rose 22% year-on-year to 720,000 ounces, driven by a 28% increase in managed operations, including strong output from Siguiri (67% increase), Sukari (Egypt’s largest gold mine, contributing 117,000 ounces), and other African mines.
The company reported a 607% surge in free cash flow to $403 million and a 764% increase in profit attributable to shareholders, reaching $443 million in Q1 2025, reflecting operational improvements, cost management, and higher gold prices.
AngloGold Ashanti is investing heavily in expansion, notably a $500 million redevelopment of the Obuasi mine in Ghana, aiming to increase production to 400,000 ounces per annum by 2028 and extend the mine life by 20 years.
Why Invest in AngloGold Ashanti?
Strong Operational Growth and Financial Performance: The company’s recent production increases, significant profit and cash flow growth, and effective cost control demonstrate robust operational execution and resilience amid inflationary pressures.
Strategic Expansion In Africa: With major projects like the Obuasi redevelopment and a diversified portfolio of high-quality African mines, AngloGold Ashanti is well-positioned to capitalize on Africa’s rich gold reserves and rising gold prices.
Read Now: The Small Cap Gold Market is Breaking Out Aggressively — Here’s What to Do
3. Kinross Gold Corporation (KGC)
Kinross Gold Corporation (NYSE: KGC) is a senior gold mining company with significant operations in Africa, notably in Mauritania (Tasiast mine) and Ghana, alongside other global sites.
Recent Highlights:
In Q1 2025, Kinross Gold produced approximately 512,000 gold equivalent ounces with an attributable all-in sustaining cost of $1,355 per ounce sold. Operating cash flow reached $597 million, and free cash flow more than doubled year-over-year to about $371 million.
Cash and cash equivalents increased to $695 million, with total liquidity around $2.3 billion as of March 31, 2025. Net debt was reduced to approximately $540 million, reflecting improved balance sheet strength.
Production costs and margins improved despite inflationary pressures, with margins per ounce sold increasing 67%, outpacing the 38% rise in gold prices. Ongoing exploration and development focus includes brownfield projects at Tasiast (Mauritania) and Paracatu (Brazil), supporting future growth.
Why Invest in Kinross Gold Corporation?
STRONG FINANCIAL POSITION AND CASH FLOW GENERATION: Kinross’s robust free cash flow, reduced debt, and ample liquidity provide financial flexibility and support shareholder returns.
OPERATIONAL RESILIENCE AND DISCIPLINED GROWTH: Despite a slight production dip due to planned mine transitions, the company improved margins significantly, demonstrating effective cost management and operational excellence.
STRATEGIC EXPOSURE TO AFRICAN GOLD ASSETS: Kinross’s African operations, particularly Tasiast, offer access to high-quality gold reserves in politically stable jurisdictions, enhancing long-term production potential.
4. TRX Gold Corporation (TRX)
TRX Gold Corporation (NYSEAMERICAN: TRX) is a growing gold mining company advancing the Buckreef Gold Project in Tanzania, which features an established open pit operation and a 2,000 tonnes per day processing plant. The company recently filed a Preliminary Economic Assessment (PEA), which indicates a strong economic potential for expansion, including upgrading the plant to 3,000 tonnes per day and transitioning to underground mining within 2-3 years.
Recent Highlights:
The PEA estimates average gold production of about 62,000 ounces per year over a 17.6-year mine life, with a pre-tax net present value (NPV) of approximately US$701 million at a 5% discount rate and a life-of-mine gold price of US$2,296/oz.
The project hosts measured and indicated mineral resources of 10.8 million tonnes at 2.57 g/t gold (893,000 ounces) and inferred resources of 9.1 million tonnes at 2.47 g/t (726,000 ounces).
Recent operational improvements include increased grade profiles leading to lower cash costs and higher profitability. The company is pursuing further exploration and development to increase mineral resources and production capacity.
TRX Gold holds a special mining license in Tanzania that allows for underground mining and unrestricted growth potential. Challenges include managing underground development risks and ongoing discussions with the Tanzanian government regarding joint venture shares.
Why Invest in TRX Gold Corporation?
HIGH-MARGIN, DE-RISKED ASSET IN A PREMIER AFRICAN GOLD JURISDICTION: Buckreef is a well-established operation with expansion potential, providing a stable platform for growth.
STRONG ECONOMIC OUTLOOK AND GROWTH POTENTIAL: The PEA indicates robust project economics with significant NPV, and ongoing exploration could further enhance resources and production.
5. Perseus Mining Limited (PRU)
Perseus Mining Limited (PRU.TO) is a multi-mine gold producer and developer focused on West Africa and Tanzania, with operations in Ghana, Côte d’Ivoire, and Tanzania. The company operates three gold mines—Yaouré and Sissingué in Côte d’Ivoire, and Edikan in Ghana—and is advancing the development of the Nyanzaga Gold Project in Tanzania, as well as the CMA underground project at Yaouré.
Recent Highlights:
Perseus expects total gold production of 2.6 to 2.7 million ounces over the five-year period from FY26 to FY30, averaging about 515,000 to 535,000 ounces annually from its four operating mines. In the December 2024 quarter, Perseus produced 132,419 ounces of gold, a 9% increase from the prior quarter, at an all-in site cost (AISC) of $1,127/oz.
The company generated $173 million in notional cash flow during the quarter, with a cash margin of $1,303/oz on a realized gold price of $2,430/oz. Perseus ended December 2024 with $704 million in net cash and bullion, providing strong liquidity to fund growth and shareholder returns.
The Nyanzaga Gold Project in Tanzania is under development with a Final Investment Decision (FID) made in April 2025, involving a $523 million investment. The project is expected to produce first gold in Q1 2027, with an estimated 2.01 million ounces over an 11-year mine life and an average AISC of $1,211/oz.
Perseus maintains a strong focus on exploration to extend mine lives and grow resources, with positive results at several sites including Yaouré, Sissingué, Edikan, and the Meyas Sand project in Sudan.
Why Invest in Perseus Mining Limited?
ROBUST PRODUCTION OUTLOOK AND STRONG CASH FLOW: Perseus’s multi-mine portfolio in West Africa and Tanzania provides steady gold production with efficient cost management, supporting solid cash flow generation.
GROWTH THROUGH DEVELOPMENT PROJECTS: The Nyanzaga Gold Project and CMA underground mine represent significant growth catalysts, expanding production capacity and extending mine life.
STRONG FINANCIAL POSITION: With over $700 million in net cash and bullion, Perseus is well-capitalized to fund ongoing development and exploration, reducing financing risk.
EXPERIENCED MANAGEMENT AND PROVEN TRACK RECORD: Perseus has successfully developed and operated multiple mines in Africa, demonstrating operational expertise in the region.
Conclusion
Among the five compelling gold stocks in African markets, Lake Victoria Gold stands out as the most attractive investment opportunity due to its strategic positioning in a prolific gold district, significant upside potential, strong partnerships and financial backing, along with focused and lean operation. Furthermore, recent license renewals and successful capital raises have reduced regulatory and financial risks, providing a solid foundation for project advancement. This stability is crucial in a sector where regulatory and financial hurdles can significantly impact project timelines and costs, which makes it the best stock to invest in for those looking to capitalize on the African gold renaissance.
Join the Discussion in the WVC Facebook Investor Group
Do you have a stock tip or news story suggestion? Please email us at: invest@wealthyvc.com
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.
Wealthy VC and its employees are not Registered Investment Advisors, Broker-Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Wealthy VC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and Wealthy VC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Our website and newsletter are for entertainment purposes only. This website is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
Release of Liability: Through the use of this email and/or website advertisement, by viewing or using it, you agree to hold Wealthy VC, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Wealthy VC-sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by Wealthy VC or an offer or solicitation to buy or sell any security. WealthyVC and our controlling entity 1000724287 Ontario Ltd have been compensated USD $7,500 per month for six months for investor relations by Shuttle Pharmaceuticals Holdings, Inc.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead, Wealthy VC strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D and all reports published on SEDAR if the company featured is Canadian. Wealthy VC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors with a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements”. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day’s closing price and the high of-day price during our promotional coverage.
In preparing this publication, Wealthy VC has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, Wealthy VC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of material facts from such advertisement. Wealthy VC is not responsible for any claims made by the companies advertised herein, nor is Wealthy VC responsible for any other promotional firm, its program or its structure.
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations
Shuttle Pharmaceuticals (NASDAQ: SHPH) is doubling down on its mission to revolutionize cancer treatment with radiation therapy. In just a few short weeks, the company has achieved a series of notable milestones, from a promising Phase 2 trial update to the appointment of veteran biotech executive George Scorsis as Chairman of the Board.
With its lead candidate Ropidoxuridine already making waves in glioblastoma trials, Shuttle Pharma is positioning itself at the forefront of oncology innovation. The moves come as Shuttle looks to emulate recent breakthroughs by industry leaders such as Lantheus Holdings (NASDAQ: LNTH) and Novartis (NYSE: NVS), both of which have brought radiopharmaceutical therapies to market using similar underlying science.
George Scorsis Steps In as Chairman
On Wednesday, Shuttle Pharma announced George Scorsis as the new Chairman of its Board of Directors. Scorsis brings over 25 years of executive experience, particularly in highly regulated sectors including biotech and cannabis. His resume includes leadership roles at Liberty Health Sciences and Mettrum Health Corp., and he currently chairs both Awakn Life Sciences (CSE: AWKN) (OTCQB: AWKNF) and Entourage Health Corp.
Commenting on his new role at Shuttle, Scorsis stated:
I am honored to take on the role of Chairman of Shuttle Pharma. The Company has a unique opportunity to leverage its radiation sensitizers to increase cancer cure rates, prolong patient survival and improve quality of life for patients suffering from glioblastoma. I look forward to providing guidance to support the Company as we look to improve the lives of millions of patients impacted by cancer.
Scorsis also previously served as Chairman of SOL Global Investments (CSE: SOL) (OTC: SOLCF), which further illustrates his deep involvement in pioneering healthcare ventures.
His appointment reflects Shuttle’s strategic push to strengthen its leadership team as it enters a pivotal period of clinical and commercial development.
Ropidoxuridine Phase 2 Trial Gains Momentum
The heart of Shuttle Pharma’s pipeline is Ropidoxuridine (IPdR), a novel radiation sensitizer currently in Phase 2 clinical trials for the treatment of glioblastoma. The aggressive brain cancer has limited treatment options and remains incurable. Shuttle’s approach aims to amplify the efficacy of radiation therapy while keeping side effects minimal.
As of May 8, 2025, nearly 50% of the trial’s initial enrollment target had been met. Impressively, 84% of patients enrolled had completed all seven cycles of treatment. Trial sites—ranging from Georgetown University Medical Center to the Miami Cancer Institute—reported the drug was well tolerated, with toxicity scores not exceeding 2 on a 1-5 scale.
Dr. Anatoly Dritschilo, who recently stepped down as Chairman and Chief Scientific Officer, said, “If approved, we believe that Ropidoxuridine has the potential to redefine the standard approach for how to care for patients with glioblastoma.”
Patients are being randomized into two dose cohorts—1,200 mg/day and 960 mg/day—to determine the optimal regimen. Once identified, an additional 14 patients will be enrolled at the best dose to reach statistical significance. The trial aims to complete enrollment later this year, with data readouts expected in 2026.
Chris Cooper, Shuttle’s interim CEO, commented:
With nearly 50% of patient enrollment achieved in the initial randomized portion and 84% of enrolled patients completing all seven cycles, the trial is advancing steadily at esteemed cancer centers. Ropidoxuridine has been well-tolerated and we have begun analyzing pharmacokinetic and pharmacodynamic samples to optimize dosing and response. Our goal is to complete enrollment later this year, with follow-up and data readouts anticipated in 2026.
The U.S. FDA has granted Orphan Drug Designation to Ropidoxuridine, giving Shuttle potential marketing exclusivity if approved. Given that an estimated 800,000 U.S. cancer patients undergo radiation therapy annually—and 400,000 of those for curative purposes—Shuttle’s target market is sizable and growing.
Innovation Extends Beyond the Clinic
On May 15, 2025, Shuttle released a corporate update highlighting the company’s many recent developments. In addition to clinical progress, Shuttle has made strides in the diagnostics space. The company entered a sponsored research agreement with the University of California, San Francisco (UCSF) to develop a PSMA-targeted ligand for theranostic use in prostate cancer.
Furthermore, Shuttle filed a provisional patent titled “PSMA-Targeted PARP Inhibitor Conjugates for Precision Cancer Therapy.” The filing was developed with Dr. Alan Kozikowski, a medicinal chemist whose past work helped enable the development of Lantheus’ Pylarify and Novartis’ Pluvicto—two commercially successful radiopharmaceuticals.
Shuttle’s recent underwritten public offering helped solidify its financial footing, with $4.5 million in cash and equivalents reported as of March 31, 2025. That cash will fund both the ongoing clinical trial and preclinical research efforts.
Strengthened Leadership Amid Key Transitions
While Scorsis’ arrival marks a new chapter, Shuttle has also seen notable exits. Dr. Dritschilo resigned from the Board and his role as CSO, while Michael Vander Hoek, the company’s VP of Regulatory, announced his retirement effective June 10.
New board members Oleh Nabyt and Joseph Tung join Scorsis in reinforcing Shuttle’s governance and bringing expanded business and legal acumen to the table.
Looking Ahead
Shuttle Pharmaceuticals appears to be building momentum across multiple fronts—clinical, intellectual property, diagnostics, and leadership. With a new Chairman in place, promising mid-trial results, and a strengthened pipeline backed by a scientific pedigree, the company is drawing comparisons to past success stories, such as Lantheus Holdings and Novartis.
Investors will watch closely as the Ropidoxuridine trial progresses toward full enrollment and data publication in 2026. If Shuttle can successfully deliver on its ambitions, it could play a major role in transforming radiation therapy for cancer patients worldwide.
Read Next: This Biotech Stock Took The Center Stage at the Planet MicroCap Showcase: VEGAS 2025
Join the Discussion in the WVC Facebook Investor Group
Do you have a stock tip or news story suggestion? Please email us at: invest@wealthyvc.com.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.
Wealthy VC and its employees are not Registered Investment Advisors, Broker-Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Wealthy VC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and Wealthy VC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Our website and newsletter are for entertainment purposes only. This website is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
Release of Liability: Through the use of this email and/or website advertisement, by viewing or using it, you agree to hold Wealthy VC, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Wealthy VC-sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by Wealthy VC or an offer or solicitation to buy or sell any security. WealthyVC and our controlling entity 1000724287 Ontario Ltd have been compensated USD $7,500 per month for six months for investor relations by Shuttle Pharmaceuticals Holdings, Inc.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead, Wealthy VC strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D and all reports published on SEDAR if the company featured is Canadian. Wealthy VC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors with a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements”. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day’s closing price and the high of-day price during our promotional coverage.
In preparing this publication, Wealthy VC has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, Wealthy VC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of material facts from such advertisement. Wealthy VC is not responsible for any claims made by the companies advertised herein, nor is Wealthy VC responsible for any other promotional firm, its program or its structure.
Golden Cross Resources (TSX-V:AUX): Tapping into Australia’s Next Great Gold Story
If you’ve been following the gold exploration game in Canada, you’ll know the TSX-V is reaching some absurd highs after the recent rebound.
TSX-V: 12 months
If you’ve been following the gold exploration game in Australia, you’ll know that Victoria’s Sunday Creek discovery by Southern Cross Gold has been one of the most impressive finds in recent years.
Southern Cross Resources (SXGC.VN) 2 Year Chart
From $0.41 to over $6.00, It’s become a $1.3 billion-dollar story that started small, and is now big, very big.
But what’s next?
What if you missed that boat?
What else can be in line to find a discovery of that nature?
I watched K92 explode, I’ve watched SXGC explode, (as I’m close friends with their CFO, Nick Demare) and now it’s no exaggeration to say Golden Cross Resources (TSXV: AUX) could be next in line for a headline-making discovery.
Golden Cross Deck, May, 2025
Before we dive into why, let’s understand the basics.
Golden Cross is a tight, lean exploration company laser-focused on high–grade gold.
Their flagship project, Reedy Creek, sits just 10km northeast, and directly contiguous, to Southern Cross Gold’s famed Sunday Creek project.
It’s like the quiet kid who always wanted to date the most popular girl in school… No one paid much attention to him until he ditched the pocket protector, hit the gym, and now she’s the one chasing him!
Ok, here’s the deal:
Golden Cross’ Reedy Creek project is not some grass-roots dream.
It’s a historic goldfield that’s already delivered monster results in past drilling, like 11m at 31.4g/t gold.
And an absurd 2m at 174.4 g/t gold.
Let’s be real, you could throw a dart at a board of every asset on earth and couldn’t find something half as interesting as this one.
Still reading? Good, it gets better.
The Ladder
They’re applying the same “Testing the Ladder” exploration model that turned Sunday Creek from a curiosity into a billion-dollar soon to be mine.
For those who missed the Southern Cross story, that’s the approach where shorter holes (100-200m) are drilled systematically across a structure, helping to define the geometry of the high-grade “ladder” style veins.
It’s like checking every step of the ladder before climbing up further to the top.
Golden Cross is undertaking a comprehensive resampling program.
They are taking those historic drill cores and applying modern QA/QC techniques to verify grades, look for pathfinder elements (like antimony), and refine the geological model.
And to me, that’s a smart move. Smart before spending the real dollars.
Read Now: The Small Cap Gold Market is Breaking Out Aggressively — Here’s What to Do
A Drill Plan with Real Firepower
It’s one thing to talk about exploration; it’s another to put your money where your mouth is.
Golden Cross is fully funded for a 6,000-meter drill program thats well underway.
The plan is simple but powerful: start with one drill rig in June, and ramp up to two rigs in September.
Golden Cross Drill Campaign Targets, June 2025
That means steady news flow on assays rolling in from August to December, prime time for the market’s, and even more prime time with 52 week highs on the venture right now.
Drilling costs are competitive at approximately CAD $230 per meter (including assays), and with the ability to drill 12 months a year, they’re not stuck to the seasons like some of their northern counterparts. (Read: Canada)
That’s a serious advantage.
The Location, The Neighbours, and The Big Prize
If real estate is all about “location, location, location,” then mining is all about geology, geology, geology, and this patch of ground is primed.
Reedy Creek sits on a NW-SE gold-in-soil anomaly that runs for 3km, parallel to a 7km anticline structure.
That’s the kind of structural setting that has delivered big deposits across Victoria.
Southern Cross’ Sunday Creek project is sitting right next door.
With Southern Cross already demonstrating high-grade gold veins in a 135-meter-wide zone, Golden Cross is betting on the same geological recipe at Reedy Creek.
If they’re right, this could be a gold system that just keeps on giving.
The Team: Proven Builders
In mining, the best rocks in the world mean nothing without the right team to bring them out of the ground.
A team with the know how and experience.
Golden Cross has stacked the deck with proven discoverers and dealmakers.
CEO Matthew Roma, formerly CFO of Snowline Gold and Gladiator Metals, (who also grew up on the North Shore of Vancouver, like yours truly) knows how to raise capital (over $150 million)and build companies that attract the big boys.
On the exploration side, VP Alan Till brings 17+ years of discovery experience from Black Rock Mining’s Mahenge Graphite deposit and Odin Metals, among others.
Add in director, Darryl Cardey, one of the original Co-founders and Directors of K92:
K92 Mining 10 Year Chart
And you have a leadership team that’s all impeccable, no filler.
If there’s gold in them there hills, these guys will find it.
The Share Structure: Tight and Right
Nothing kills a story faster than a bloated cap table.
With just 60 million shares out, and 33% of that held by insiders and close associates, Golden Cross has one of the tightest structures around.
Golden Cross Structure – May, 2025
That means when the news starts to flow, and assuming the drills hit what they think they’re going to hit, there’s serious movement for shareholders.
And that excites me. (Although I don’t own any yet, I may pick some up in the market)
The VRIFY Advantage
Let’s not forget that Golden Cross is embracing the 21st century with VRIFY’s AI exploration tool.
Southern Cross Gold used VRIFY to guide their billion dollar Sunday Creek discovery…
And now Golden Cross is deploying the same technology and the same technical team, applying proven methods to unlock Reedy Creek’s high-grade gold potential.
VRIFY AI Tech
This technology helps identify high priority drill targets faster and more accurately than anything I’ve ever seen.
It’s like giving Indiana Jones a drone and a metal detector!
Here’s where the rubber meets the road.
With drilling well underway, and assays rolling in from August onward, Golden Cross is on the cusp of delivering the kind of steady news flow that junior exploration investors dream about.
In a market where timing is everything, this is the moment when early investors can position themselves for a potential breakout, and in the heart of the summer doldrums.
Golden Cross is not just another gold junior.
It’s a tight, well-managed, small team, fully funded company sitting on the doorstep of one of Australia’s most exciting gold discoveries.
With a track record of high-grade intersections, a proven exploration model, a world-class team, a tight share structure, and a brand new listing; it has all the ingredients for a potential discovery that could turn heads, and portfolios.
That’s why I’m covering it now.
If you missed the billion-dollar run at Sunday Creek, you might just have a second chance with Golden Cross.
Like a prospector in the 1850s, the time to stake your claim is now, before the rush! (Cheese not included)
For the full details, I recommend reviewing the latest investor presentation here: Golden Cross Investor Presentation
As always, do your own due diligence, and… Happy Hunting!
About The Net Worth Club
Welcome to The Net Worth Club — a no-fluff, high-conviction investing newsletter written for people who want to grow their wealth intelligently and aggressively.
Every week, I break down actionable opportunities across the stock market, private deals, and the global economy — all with one goal in mind: help you multiply your net worth.
You’ll get:
✅ Deep dives on overlooked companies with potential to double (or more)
✅ Real-time trade ideas and portfolio updates — I eat my own cooking
✅ Market psychology, timing strategies, and hard-earned lessons
✅ A front-row seat to how I’m building serious wealth — and helping others do the same
This isn’t financial fluff or recycled headlines. It’s boots-on-the-ground insight, from someone who’s in the trenches — raising capital, taking companies public, and making real bets with real money.
If you’ve ever thought: “I just want someone sharp to help me spot the big moves early” — this is for you.
👇 Subscribe now and start compounding smarter:
Read Next: Is This Tiny Biotech Stock Ready for a Massive Breakout?
Join the Discussion in the WVC Facebook Investor Group
Do you have a stock tip or news story suggestion? Please email us at: invest@wealthyvc.com
Disclaimer: The Net Worth Club shares background information and insights on early-stage companies using publicly available sources. We do not provide investment advice, we are not financial advisors, and nothing we write should be interpreted as a recommendation to buy or sell securities. Our content is intended solely for informational and educational purposes. The information we present may not be complete, accurate, or up to date. If you’re interested in a company mentioned in this newsletter, we strongly encourage you to do your own research and consult directly with the company or your licensed investment advisor. From time to time, The Net Worth Club may be compensated by companies featured in this newsletter for awareness campaigns. This creates a conflict of interest and impacts our objectivity. Additionally, the principals of The Net Worth Club may hold, buy, or sell shares of mentioned companies at any time without notice. We are not registered or licensed by any securities regulatory authority in any jurisdiction. Always do your own due diligence and speak with a licensed financial professional before making any investment decisions. Investing carries risk. Never invest money you can’t afford to lose. This newsletter is not a solicitation or offer to buy or sell any securities, nor is it a guarantee of performance. Any references to past or potential performance are not indicative of future results.
Wealthy VC does not hold a position in any of the stocks, ETFs or cryptocurrencies mentioned in this article.
Liposuction in Dubai with Dr. Hüseyin Kandulu: A Premium Approach to Body Contouring
In the heart of the UAE, Dubai has emerged as a global hub for luxury medical tourism, especially in the field of aesthetic surgery. Among the leading experts in this evolving landscape is Dr. Hüseyin Kandulu, a renowned plastic surgeon offering advanced liposuction procedures. Patients from around the world seek his services not only for his artistic eye and surgical precision, but also for his personalized approach to body shaping. If you're considering liposuction in Dubai, this comprehensive guide will walk you through the process, benefits, techniques, and what to expect when working with Dr. Hüseyin Kandulu.
Who Is Dr. Hüseyin Kandulu?
Dr. Hüseyin Kandulu is a highly respected plastic surgeon with years of international experience in cosmetic surgery, particularly liposuction, body contouring, and VASER liposuction. With a modern approach rooted in natural aesthetics, he has gained a reputation for delivering tailored, high-quality results that align with each patient’s unique body type and goals.
His practice in Dubai combines world-class medical technology with a boutique clinic experience, providing an exceptional level of comfort and professionalism for patients seeking cosmetic transformation.
Why Choose Dubai for Liposuction?
Dubai offers more than just luxury shopping and iconic skyscrapers—it is now one of the top destinations for aesthetic procedures. Here’s why so many patients opt for liposuction in Dubai:
- State-of-the-art clinics with internationally accredited standards
- Access to globally trained surgeons like Dr. Kandulu
- Fast scheduling with little to no waiting lists
- Confidential and discreet treatment environment
- A luxurious medical tourism experience that includes five-star recovery services
Dubai also makes an ideal location for a recovery vacation, with its serene beaches, premium hotels, and top-notch wellness services.
What Makes Dr. Kandulu's Liposuction Technique Unique?
Unlike traditional fat removal methods, Dr. Kandulu employs advanced liposuction techniques, such as VASER liposuction, to sculpt the body with minimal trauma and a faster recovery. VASER (Vibration Amplification of Sound Energy at Resonance) uses ultrasound technology to selectively break down fat cells without damaging surrounding tissues.
Key Advantages of Dr. Kandulu’s Liposuction Method:
- Minimally invasive, with small incisions
- Shorter recovery time compared to traditional liposuction
- Enhanced skin tightening and contouring
- Reduced bruising and swelling
- Precise fat removal for sculpted, athletic results
Dr. Kandulu approaches each liposuction case like an artist, focusing not just on fat removal, but also on creating a harmonious, natural body shape.
Who Is an Ideal Candidate for Liposuction?
Liposuction is not a weight loss method, but rather a body sculpting technique. Ideal candidates typically meet the following criteria:
- Are at or near their ideal weight
- Have localized fat deposits resistant to diet and exercise
- Possess good skin elasticity
- Are in good overall health
- Have realistic expectations
During the initial consultation in Dubai, Dr. Kandulu performs a thorough assessment to determine if liposuction is the right option for the individual’s body and goals.
Areas Commonly Treated with Liposuction
Dr. Hüseyin Kandulu customizes each treatment plan based on the patient’s needs. Some of the most common areas he treats include:
- Abdomen and flanks (“love handles”)
- Thighs (inner and outer)
- Back and bra-line fat
- Upper arms
- Chin and neck
- Chest (particularly for male gynecomastia treatment)
Each session can target multiple areas, offering a more comprehensive transformation with a balanced silhouette.
The Consultation Process in Dubai
Your liposuction journey with Dr. Kandulu begins with a personal consultation at his clinic in Dubai. Here’s what to expect:
- Medical history and lifestyle review
- Physical examination and body analysis
- Discussion of goals, concerns, and desired results
- Overview of the procedure, techniques, and expected outcomes
- A customized treatment plan, including cost, type of anesthesia, and recovery timeline
This personalized attention ensures the procedure aligns with your aesthetic vision and overall well-being.
Recovery After Liposuction in Dubai
Thanks to Dr. Kandulu’s expertise and minimally invasive methods, recovery is smoother than many anticipate. Here’s a general timeline:
- 1–2 days of rest recommended post-surgery
- Compression garments are worn for a few weeks
- Most patients return to normal activities within 5–7 days
- Strenuous activities can resume in 3–4 weeks
Swelling and minor bruising may last for a few weeks, while results continue to improve over the following 2–3 months. Dubai’s luxury accommodations and wellness centers make the healing process more comfortable and enjoyable.
What Results Can You Expect?
While every patient is different, liposuction results with Dr. Kandulu are known for being:
- Natural-looking and balanced
- Long-lasting with proper diet and exercise
- Highly satisfying, with improved confidence and body image
Photos and testimonials from previous patients often highlight remarkable transformations, especially in cases of abdominal sculpting, waistline contouring, and male chest reshaping.
Cost of Liposuction in Dubai with Dr. Kandulu
The cost of liposuction in Dubai varies depending on the treatment area(s), technique used, and the complexity of the case. However, pricing with Dr. Kandulu reflects both the premium quality of care and the advanced technology involved.
Though not the most budget-friendly option, it is a worthwhile investment...—particularly when performed by a surgeon with Dr. Kandulu’s expertise and track record.
Traveling to Dubai for Liposuction: What You Need to Know
International patients are welcomed with open arms. Dr. Kandulu’s team offers support with:
- Medical visa guidance
- Airport transfers
- Hotel recommendations
- Translation services (if needed)
- Aftercare coordination
Many patients plan a medical holiday, combining body transformation with a luxurious escape. Dubai’s safety, modern infrastructure, and hospitality industry make it easy to focus on recovery in comfort.
Final Thoughts: Is Liposuction in Dubai with Dr. Kandulu Right for You?
Choosing to undergo liposuction in Dubai with Dr. Hüseyin Kandulu means choosing world-class results in a luxurious, medically advanced setting. Whether you're targeting stubborn fat or seeking a more defined, athletic figure, Dr. Kandulu’s personalized and precise approach ensures you’ll leave with renewed confidence and a rejuvenated body.
If you’re ready to take the next step in your aesthetic journey, a consultation with Dr. Kandulu could be the beginning of your transformation.
Contact: https://en.huseyinkandulu.com/
ZenaTech’s ZenaDrone Launches the IQ Nano Indoor Drone for US Defense Applications and Initiates Green and Blue UAS Certifications
(Vancouver, British Columbia– June 17, 2025) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE:
49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial
Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum
Computing solutions, today announces the launch of the ZenaDrone’s IQ Nano, a
compact autonomous indoor drone, for US Department of Defense (DoD) agencies and
government use to innovate applications including inventory management, facility
security, and search and rescue. Following recent US Executive Order policy directives
aimed at fast-tracking DoD adoption of secure US-made drones and streamlining
procurement, the company plans to apply for Green UAS (Unmanned Aerial System)
certification, followed by Blue UAS certification required to be officially recognized as a
secure and mission-ready drone supplier to US military customers.
“New policy directives have cleared regulatory hurdles and aligned procurement to
supercharge US defense drone manufacturers,” said Shaun Passley, Ph.D., CEO of
ZenaTech. “As defense agencies navigate an increasingly complex security and
logistics landscape, autonomous AI technologies like the IQ Nano indoor drone are
critical to maintain a tactical edge. By automating and streamlining tasks like inventory
management, security, reconnaissance, and search and rescue, it frees personnel to
focus on strategic decision-making, ultimately enhancing mission success and
protecting lives.”
The IQ Nano drone is engineered for operations in GPS-denied, confined, or high-risk
environments where traditional systems and personnel face operational challenges. It
automates inventory management by precisely scanning barcodes of stock in armories
and warehouses, reducing manual labour, human errors and improving safety.
Equipped with HD and thermal imaging plus AI-powered anomaly detection, it enables
secure indoor surveillance of command centers, ammunition depots, and restricted
zones. Its stable hover capabilities, obstacle avoidance, and durable Carbon-fiber
design ensure safe operation in confined spaces.
The drone’s autonomous flight and night vision capabilities support search and rescue
by navigating dark, collapsed, or inaccessible areas to locate personnel, deliver
supplies, and monitor for threats. Compact and rapidly deployable, the IQ Nano
enhances agility across defense infrastructure and logistics.
Beyond these capabilities, the IQ Nano can support facility mapping and digital twin
creation (virtual 3D model of a facility) to aid mission planning, maintenance, and
infrastructure analysis. Additionally, it can also contribute to combat training and
simulation exercises by replicating reconnaissance scenarios and capturing
performance data in controlled environments.
The IQ Nano is designed to operate not just as a single unit but as a part of a drone
fleet or swarm. In indoor military environments, these coordinated fleets can cover
expansive or complex facilities simultaneously, enabling faster inventory audits,
comprehensive surveillance, and enhanced situational awareness.
The company plans to initiate the Green UAS certification process for the IQ Nano
which is considered a pathway to the Blue UAS certification list. The main difference is
that the Green UAS is a commercial certification for secure drones led by the AUVSI
drone industry association. The Blue UAS is a military-grade approval managed by the
DoD, which includes additional security and performance evaluations and a strict
country of origin requirement that must not include Chinese suppliers.
About ZenaTech
ZenaTech (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company
specializing in AI drone, Drone as a Service (DaaS), enterprise SaaS and Quantum
Computing solutions for mission-critical business applications. Since 2017, the
Company has leveraged its software development expertise and grown its drone design
and manufacturing capabilities through ZenaDrone, to innovate and improve customer
inspection, monitoring, safety, security, compliance, and surveying processes. With
enterprise software customers using branded solutions in law enforcement,
government, and industrial sectors, and drones being implemented in these plus
agriculture, defense, logistics and land survey areas, ZenaTech’s portfolio of solutions
helps drive exceptional operational efficiencies, accuracy, and cost savings. The
Company operates through seven global offices in North America, Europe, Taiwan, and
UAE, and is growing a DaaS business model and global partner network.
About ZenaDrone
ZenaDrone, a wholly owned subsidiary of ZenaTech, develops and manufactures
autonomous drone solutions that can incorporate machine learning software, AI,
predictive modeling, Quantum Computing, and other software and hardware
innovations. Created to revolutionize the hemp farming sector, its specialization has
grown to multifunctional AI drone solutions for industrial surveillance, monitoring,
inspection, tracking, process automation and defense applications. Currently, the
ZenaDrone 1000 drone is used for crop management applications in agriculture and
critical field cargo applications in the defense sector, the IQ Nano indoor drone is used
for inventory management and security in commercial sectors, and the IQ Square is an
indoor/outdoor drone designed for land surveys and inspections in the commercial and
defense sectors.
Contacts for more information:
Company, Investors and Media:
Linda Montgomery
ZenaTech
312-241-1415
investors@zenatech.com
Investors:
Michael Mason
CORE IR
investors@zenatech.com
Safe Harbor
This press release and related comments by management of ZenaTech, Inc. include
“forward-looking statements” within the meaning of U.S. federal securities laws and
applicable Canadian securities laws. These forward-looking statements are subject to
the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
This forward-looking information relates to future events or future performance of
ZenaTech and reflects management’s expectations and projections regarding
ZenaTech’s growth, results of operations, performance, and business prospects and
opportunities. Such forward-looking statements reflect management’s current beliefs
and are based on information currently available to management. In some cases,
forward-looking information can be identified by terminology such as “may”, “will”,
“should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”,
“estimate”, “predict”, “potential”, “continue” or the negative of these terms or other
comparable terminology intended to identify forward-looking statements. Forward-
looking information in this document includes, but is not limited to ZenaTech’s
expectations regarding its revenue, expenses, production, operations, costs, cash flows,
and future growth; expectations with respect to future production costs and
capacity; ZenaTech's ability to deliver products to the market as currently contemplated,
including its drone products including ZenaDrone 1000 and IQ Nano; ZenaTech’s
anticipated cash needs and it’s needs for additional financing; ZenaTech’s intention to
grow the business and its operations and execution risk; expectations with respect to
future operations and costs; the volatility of stock prices and market conditions in the
industries in which ZenaTech operates; political, economic, environmental, tax, security,
and other risks associated with operating in emerging markets; regulatory
risks; unfavorable publicity or consumer perception; difficulty in forecasting industry
trends; the ability to hire key personnel; the competitive conditions of the industry and
the competitive and business strategies of ZenaTech; ZenaTech’s expected business
objectives for the next twelve months; ZenaTech’s ability to obtain additional funds
through the sale of equity or debt commitments; investment capital and market share;
the ability to complete any contemplated acquisitions; changes in the target
markets; market uncertainty; ability to access additional capital, including through the
listing of its securities in various jurisdictions; management of growth (plans and timing
for expansion); patent infringement; litigation; applicable laws, regulations, and any
amendments affecting the business of ZenaTech.